p52sheLL Citations (1)
Originally described in: Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.Kondo K, Ochi H, Matsumoto T, Yoshikawa H, Kanda T J Med Virol. 2008 May;80(5):841-6. doi: 10.1002/jmv.21124. PubMed Journal
Articles Citing p52sheLL
| Articles |
|---|
| Serum and cervicovaginal IgG immune responses against alpha7 and alpha9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. Mboumba Bouassa RS, Pere H, Gubavu C, Prazuck T, Jenabian MA, Veyer D, Meye JF, Touze A, Belec L. PLoS One. 2020 May 18;15(5):e0233084. doi: 10.1371/journal.pone.0233084. eCollection 2020. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.